Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ALK inhibitors for treatment of ALK-negative cancer and plasma cell-mediated diseases

ALK inhibitors for treatment of ALK-negative cancer and plasma cell-mediated diseases

US Patent 12465607 · Granted Nov 11, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tertiary amines for use in the treatment of cardiac disorders2018
Cyclic amino compounds for use in the treatment of cardiac disorders2017
Tertiary amines for use in the treatment of cardiac disorders2017
Purine nucleotide derivatives2012
Methods of treating and preventing AIDS using of COX-2 inhibitors2010
Use of a preparation based on an antibody directed against a tumor-associated gl2009
Use of immunomodulating agents2007